Nasdaq · CIK 0000856982
MMSI MERIT MEDICAL SYSTEMS INC
Insider trading from SEC Form 4. Last filing 33 d ago. Close $87.21 on Oct 9, 2026, +45% from the 52-week low and -6% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
15
with a Form 4 at this company
Price and insider trades, last year
MMSIOct 9, 2026 · close 87.21
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at MERIT MEDICAL SYSTEMS INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Fred P. Lampropoulos Executive Chairman sell | $880k 10,000 shares | -1% | +11% from low-21% from high | |
| 45Moderate | Fred P. Lampropoulos Executive Chairman sell | $2.2M 25,000 shares | -2% | +10% from low-21% from high | |
| 45Moderate | Fred P. Lampropoulos Executive Chairman sell | $1.7M 20,000 shares | -2% | +7% from low-23% from high | |
| 36Weak | Fred P. Lampropoulos Executive Chairman sell | $424k 5,000 shares | -0% | +7% from low-24% from high | |
| 18Weak | Lynne N. Ward director sell | $266k 3,000 shares | -19% | +8% from low-19% from high | |
| 17Weak | Lynne N. Ward director sell | $207k 2,433 shares | -16% | +1% from low-24% from high | |
| 57Moderate | Raul Parra Jr. CFO AND TREASURER sell | $1.4M 15,181 shares | -39% | +5% from low-16% from high | |
| 46Moderate | Fred P. Lampropoulos President and CEO sell | $38k 400 shares | -0% | +8% from low-14% from high | |
| 64Notable | Fred P. Lampropoulos President and CEO sell | $952k 10,000 shares | -1% | +8% from low-14% from high | |
| 35Weak | David Floyd director sell | $331k 3,515 shares | -42% | +7% from low-14% from high | |
| 64Notable | Fred P. Lampropoulos President and CEO sell | $951k 10,000 shares | -1% | +7% from low-14% from high | |
| 35Weak | Michael R. McDonnell director sell | $330k 3,500 shares | -35% | +7% from low-14% from high | |
| 65Notable | Fred P. Lampropoulos President and CEO sell | $1.9M 20,000 shares | -2% | +9% from low-13% from high | |
| 23Weak | F. Ann Millner director sell | $2.0M 21,250 shares | -38% | +10% from low-12% from high | |
| 8Weak | Neil Peterson CHIEF OPERATING OFFICER sell | $523k 5,000 shares | -15% | +12% from low-4% from high | |
| 58Moderate | Fred P. Lampropoulos President and CEO sell | $3.6M 34,320 shares | -3% | - | |
| 61Notable | Stephen C. Evans director sell | $527k 5,000 shares | -52% | - | |
| 30Weak | F. Ann Millner director sell | $1.3M 12,500 shares | -28% | - | |
| 46Moderate | Raul Parra Jr. CFO AND TREASURER sell | $548k 5,361 shares | -25% | - | |
| 67Notable | Raul Parra Jr. CFO AND TREASURER sell | $2.9M 29,646 shares | -64% | - | |
| 48Moderate | Neil Peterson CHIEF OPERATING OFFICER sell | $490k 5,000 shares | -25% | - |
Congressional trades
2 trades in MMSI disclosed by members of Congress under the STOCK Act. All congressional trades.
- Lisa C. McClainHouse · R-MI · last Oct 22, 20251 bought
1 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Lisa C. McClain House · R-MI | Sale | MMSI Merit Medical Systems, Inc. - Common Stock | $1,001 to $15k | Sep 25, 2025 / Oct 22, 2025 27 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Purchase | MMSI Merit Medical Systems, Inc. - Common Stock | $1,001 to $15k | Jul 22, 2025 / Aug 13, 2025 22 days after the trade | Clerk |
Transactions
The last 81 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Sheri Lewis EVP of Global Operations | AGrant or award Common Stock, No Par Value | +8,371 | $0.00 | $0 | 8,371 | 33 d ago |
| Feb 26, 2026 | Martha Goldberg Aronson President and CEO | AGrant or award Common Stock, No Par Value | +28,198 | $0.00 | $0 | 47,792 | Mar 2, 2026 |
| Nov 25, 2025 | Fred P. Lampropoulos Executive Chairman | SOpen-market sale Common Stock, No Par Value | -10,000 | $88.04 | $880k | 1,019,955 | Nov 26, 2025 |
| Nov 21, 2025 | Fred P. Lampropoulos Executive Chairman | SOpen-market sale Common Stock, No Par Value | -25,000 | $87.31 | $2.2M | 1,029,955 | Nov 24, 2025 |
| Nov 20, 2025 | Fred P. Lampropoulos Executive Chairman | SOpen-market sale Common Stock, No Par Value | -20,000 | $85.13 | $1.7M | 1,054,955 | Nov 21, 2025 |
| Nov 18, 2025 | Fred P. Lampropoulos Executive Chairman | SOpen-market sale Common Stock, No Par Value | -5,000 | $84.83 | $424k | 1,074,955 | Nov 20, 2025 |
| Oct 3, 2025 | Martha Goldberg Aronson President and CEO | AGrant or award Common Stock, No Par Value | +19,594 | $0.00 | $0 | 19,594 | Oct 7, 2025 |
| Oct 3, 2025 | Martha Goldberg Aronson President and CEO | AGrant or award Common Stock, No Par Value | +19,594 | $0.00 | $0 | 19,594 | Oct 7, 2025 |
| Aug 29, 2025 | Fred P. Lampropoulos President and CEO | MOption exercise Common Stock, No Par Value | +159,151 | $55.73 | $8.9M | 1,204,779 | Sep 3, 2025 |
| Aug 29, 2025 | Fred P. Lampropoulos President and CEO | FTax withholding Common Stock, No Par Value | -124,824 | $90.54 | $11M | 1,079,955 | Sep 3, 2025 |
| Aug 29, 2025 | Fred P. Lampropoulos President and CEO | MOption exercise Common Stock, No Par Valueindirect: By spouse | +2,000 | $55.73 | $111k | 9,734 | Sep 3, 2025 |
| Aug 29, 2025 | Fred P. Lampropoulos President and CEO | FTax withholding Common Stock, No Par Valueindirect: By spouse | -1,454 | $90.54 | $132k | 8,280 | Sep 3, 2025 |
| Aug 29, 2025 | Fred P. Lampropoulos President and CEO | MOption exercise Non-qualified stock options (right to buy)derivative | -159,151 | $0.00 | $0 | 0 | Sep 3, 2025 |
| Aug 29, 2025 | Fred P. Lampropoulos President and CEO | MOption exercise Non-qualified stock options (right to buy)derivativeindirect: By spouse | -2,000 | $0.00 | $0 | 0 | Sep 3, 2025 |
| Aug 22, 2025 | Lynne N. Ward director | MOption exercise Common Stock, No Par Value | +3,000 | $34.46 | $103k | 15,809 | Aug 25, 2025 |
| Aug 22, 2025 | Lynne N. Ward director | SOpen-market sale Common Stock, No Par Value | -3,000 | $88.56 | $266k | 12,809 | Aug 25, 2025 |
| Aug 22, 2025 | Lynne N. Ward director | MOption exercise Non-qualified stock options (right to buy)derivative | -3,000 | $0.00 | $0 | 0 | Aug 25, 2025 |
| Aug 11, 2025 | Lynne N. Ward director | MOption exercise Common Stock, No Par Value | +2,433 | $34.46 | $84k | 15,242 | Aug 12, 2025 |
| Aug 11, 2025 | Lynne N. Ward director | SOpen-market sale Common Stock, No Par Value | -2,433 | $84.89 | $207k | 12,809 | Aug 12, 2025 |
| Aug 11, 2025 | Lynne N. Ward director | MOption exercise Non-qualified stock options (right to buy)derivative | -2,433 | $0.00 | $0 | 3,000 | Aug 12, 2025 |
| Jun 13, 2025 | Raul Parra Jr. CFO AND TREASURER | MOption exercise Common Stock, No Par Value | +9,681 | $56.25 | $545k | 33,882 | Jun 17, 2025 |
| Jun 13, 2025 | Raul Parra Jr. CFO AND TREASURER | MOption exercise Common Stock, No Par Value | +5,500 | $65.03 | $358k | 39,382 | Jun 17, 2025 |
| Jun 13, 2025 | Raul Parra Jr. CFO AND TREASURER | SOpen-market sale Common Stock, No Par Value | -15,181 | $93.75 | $1.4M | 24,201 | Jun 17, 2025 |
| Jun 13, 2025 | Raul Parra Jr. CFO AND TREASURER | MOption exercise Non-qualified stock options (right to buy)derivative | -9,681 | $0.00 | $0 | 0 | Jun 17, 2025 |
| Jun 13, 2025 | Raul Parra Jr. CFO AND TREASURER | MOption exercise Non-qualified stock options (right to buy)derivative | -5,500 | $0.00 | $0 | 9,070 | Jun 17, 2025 |
| Jun 10, 2025 | Fred P. Lampropoulos President and CEO | SOpen-market sale Common Stock, No Par Value | -400 | $95.61 | $38k | 1,045,628 | Jun 12, 2025 |
| Jun 5, 2025 | Fred P. Lampropoulos President and CEO | SOpen-market sale Common Stock, No Par Value | -10,000 | $95.19 | $952k | 1,046,028 | Jun 9, 2025 |
| May 30, 2025 | Michael R. McDonnell director | SOpen-market sale Common Stock, No Par Value10b5-1 | -1,750 | $94.30 | $165k | 8,145 | Jun 3, 2025 |
| May 30, 2025 | David Floyd director | SOpen-market sale Common Stock, No Par Valueindirect: David K. Floyd Living Trust10b5-1 | -3,515 | $94.16 | $331k | 4,880 | Jun 3, 2025 |
| Jun 2, 2025 | Michel J. Voigt CHIEF HUMAN RESOURCES OFFICER | GGift Common Stock, No Par Value | -55 | $0.00 | $0 | 21,724 | Jun 3, 2025 |
| Jun 2, 2025 | Michael R. McDonnell director | SOpen-market sale Common Stock, No Par Value10b5-1 | -1,750 | $94.51 | $165k | 6,395 | Jun 3, 2025 |
| May 30, 2025 | Fred P. Lampropoulos President and CEO | SOpen-market sale Common Stock, No Par Value | -10,000 | $95.12 | $951k | 1,056,028 | Jun 3, 2025 |
| May 27, 2025 | Fred P. Lampropoulos President and CEO | SOpen-market sale Common Stock, No Par Value | -20,000 | $96.54 | $1.9M | 1,066,028 | May 29, 2025 |
| May 15, 2025 | F. Ann Millner director | AGrant or award Common Stock, No Par Value10b5-1 | +2,152 | $0.00 | $0 | 34,543 | May 19, 2025 |
| May 15, 2025 | Lynne N. Ward director | AGrant or award Common Stock, No Par Value | +2,152 | $0.00 | $0 | 12,809 | May 19, 2025 |
| May 15, 2025 | Silvia Perez director | AGrant or award Common Stock, No Par Value | +2,152 | $0.00 | $0 | 4,583 | May 19, 2025 |
| May 15, 2025 | Michael R. McDonnell director | AGrant or award Common Stock, No Par Value | +2,152 | $0.00 | $0 | 9,895 | May 19, 2025 |
| May 15, 2025 | Laura S. Kaiser director | AGrant or award Common Stock, No Par Value | +2,152 | $0.00 | $0 | 9,895 | May 19, 2025 |
| May 15, 2025 | Stephen C. Evans director | AGrant or award Common Stock, No Par Value | +2,152 | $0.00 | $0 | 6,809 | May 19, 2025 |
| May 15, 2025 | Lonny J. Carpenter director | AGrant or award Common Stock, No Par Value | +2,152 | $0.00 | $0 | 17,367 | May 19, 2025 |
| May 15, 2025 | Thomas James Gunderson director | AGrant or award Common Stock, No Par Value | +2,152 | $0.00 | $0 | 36,034 | May 19, 2025 |
| May 15, 2025 | F. Ann Millner director | MOption exercise Common Stock, No Par Value10b5-1 | +21,250 | $52.17 | $1.1M | 55,793 | May 19, 2025 |
| May 15, 2025 | David Floyd director | AGrant or award Common Stock, No Par Value | +2,152 | $0.00 | $0 | 11,033 | May 19, 2025 |
| May 15, 2025 | David Floyd director | AGrant or award Common Stock, No Par Value | +2,152 | $0.00 | $0 | 11,033 | May 19, 2025 |
| May 15, 2025 | F. Ann Millner director | SOpen-market sale Common Stock, No Par Value10b5-1 | -21,250 | $96.47 | $2.0M | 34,543 | May 19, 2025 |
| May 15, 2025 | F. Ann Millner director | MOption exercise Non-qualified stock options (right to buy)derivative10b5-1 | -13,750 | $0.00 | $0 | 0 | May 19, 2025 |
| May 15, 2025 | F. Ann Millner director | MOption exercise Non-qualified stock options (right to buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 0 | May 19, 2025 |
| Apr 1, 2025 | Neil Peterson CHIEF OPERATING OFFICER | MOption exercise Common Stock, No Par Value10b5-1 | +5,000 | $54.40 | $272k | 33,369 | Apr 2, 2025 |
| Apr 1, 2025 | Neil Peterson CHIEF OPERATING OFFICER | SOpen-market sale Common Stock, No Par Value10b5-1 | -5,000 | $104.53 | $523k | 28,369 | Apr 2, 2025 |
| Apr 1, 2025 | Neil Peterson CHIEF OPERATING OFFICER | MOption exercise Non-qualified stock options (right to buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 5,000 | Apr 2, 2025 |
| Mar 5, 2025 | Fred P. Lampropoulos President and CEO | SOpen-market sale Common Stock, No Par Value | -11,320 | $104.05 | $1.2M | 1,106,028 | Mar 6, 2025 |
| Mar 5, 2025 | Fred P. Lampropoulos President and CEO | SOpen-market sale Common Stock, No Par Value | -20,000 | $103.75 | $2.1M | 1,086,028 | Mar 6, 2025 |
| Mar 5, 2025 | Fred P. Lampropoulos President and CEO | SOpen-market sale Common Stock, No Par Valueindirect: By spouse | -410 | $103.75 | $43k | 10,324 | Mar 6, 2025 |
| Mar 5, 2025 | Fred P. Lampropoulos President and CEO | SOpen-market sale Common Stock, No Par Valueindirect: By spouse | -2,590 | $103.75 | $269k | 7,734 | Mar 6, 2025 |
| Mar 3, 2025 | Stephen C. Evans director | SOpen-market sale Common Stock, No Par Value | -5,000 | $105.31 | $527k | 4,657 | Mar 4, 2025 |
| Feb 28, 2025 | Thomas James Gunderson director | MOption exercise Common Stock, No Par Value | +25,000 | $50.50 | $1.3M | 46,688 | Mar 3, 2025 |
| Feb 28, 2025 | Thomas James Gunderson director | FTax withholding Common Stock, No Par Value | -12,806 | $99.95 | $1.3M | 33,882 | Mar 3, 2025 |
| Feb 28, 2025 | Thomas James Gunderson director | MOption exercise Non-qualified stock options (right to buy)derivative | -25,000 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 27, 2025 | Fred P. Lampropoulos President and CEO | AGrant or award Common Stock, No Par Value | +30,755 | $0.00 | $0 | 1,098,506 | Mar 3, 2025 |
| Feb 27, 2025 | Fred P. Lampropoulos President and CEO | FTax withholding Common Stock, No Par Value | -13,501 | $98.50 | $1.3M | 1,085,005 | Mar 3, 2025 |
| Feb 28, 2025 | Fred P. Lampropoulos President and CEO | AGrant or award Common Stock, No Par Value | +20,384 | $0.00 | $0 | 1,105,389 | Mar 3, 2025 |
| Feb 28, 2025 | Fred P. Lampropoulos President and CEO | MOption exercise Common Stock, No Par Value | +38,002 | $44.80 | $1.7M | 1,143,391 | Mar 3, 2025 |
| Feb 28, 2025 | Fred P. Lampropoulos President and CEO | FTax withholding Common Stock, No Par Value | -26,043 | $102.04 | $2.7M | 1,117,348 | Mar 3, 2025 |
| Feb 28, 2025 | Fred P. Lampropoulos President and CEO | MOption exercise Common Stock, No Par Valueindirect: By spouse | +4,000 | $44.80 | $179k | 13,228 | Mar 3, 2025 |
| Feb 28, 2025 | Fred P. Lampropoulos President and CEO | FTax withholding Common Stock, No Par Valueindirect: By spouse | -2,494 | $102.04 | $254k | 10,734 | Mar 3, 2025 |
| Feb 28, 2025 | Fred P. Lampropoulos President and CEO | MOption exercise Non-qualified stock options (right to buy)derivative | -38,002 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Fred P. Lampropoulos President and CEO | MOption exercise Non-qualified stock options (right to buy)derivativeindirect: By spouse | -4,000 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Nov 15, 2024 | F. Ann Millner director | MOption exercise Common Stock, No Par Value10b5-1 | +12,500 | $50.50 | $631k | 44,891 | Nov 18, 2024 |
| Nov 15, 2024 | F. Ann Millner director | SOpen-market sale Common Stock, No Par Value10b5-1 | -12,500 | $101.55 | $1.3M | 32,391 | Nov 18, 2024 |
| Nov 15, 2024 | F. Ann Millner director | MOption exercise Non-qualified stock options (right to buy)derivative10b5-1 | -12,500 | $0.00 | $0 | 0 | Nov 18, 2024 |
| Nov 7, 2024 | Raul Parra Jr. CFO AND TREASURER | MOption exercise Common Stock, No Par Value | +5,361 | $37.71 | $202k | 21,722 | Nov 12, 2024 |
| Nov 7, 2024 | Raul Parra Jr. CFO AND TREASURER | SOpen-market sale Common Stock, No Par Value | -5,361 | $102.18 | $548k | 16,361 | Nov 12, 2024 |
| Nov 7, 2024 | Raul Parra Jr. CFO AND TREASURER | MOption exercise Non-qualified stock options (right to buy)derivative | -5,361 | $0.00 | $0 | 5,361 | Nov 12, 2024 |
| Nov 5, 2024 | Neil Peterson CHIEF OPERATING OFFICER | MOption exercise Common Stock, No Par Value | +5,000 | $54.40 | $272k | 19,819 | Nov 7, 2024 |
| Nov 5, 2024 | Raul Parra Jr. CFO AND TREASURER | MOption exercise Common Stock, No Par Value | +4,000 | $44.80 | $179k | 16,007 | Nov 7, 2024 |
| Nov 5, 2024 | Neil Peterson CHIEF OPERATING OFFICER | SOpen-market sale Common Stock, No Par Value | -5,000 | $98.00 | $490k | 14,819 | Nov 7, 2024 |
| Nov 5, 2024 | Raul Parra Jr. CFO AND TREASURER | MOption exercise Common Stock, No Par Value | +30,000 | $55.73 | $1.7M | 46,007 | Nov 7, 2024 |
| Nov 5, 2024 | Neil Peterson CHIEF OPERATING OFFICER | MOption exercise Non-qualified stock options (right to buy)derivative | -5,000 | $0.00 | $0 | 15,000 | Nov 7, 2024 |
| Nov 5, 2024 | Raul Parra Jr. CFO AND TREASURER | SOpen-market sale Common Stock, No Par Value | -29,646 | $98.02 | $2.9M | 16,361 | Nov 7, 2024 |
| Nov 5, 2024 | Raul Parra Jr. CFO AND TREASURER | MOption exercise Non-qualified stock options (right to buy)derivative | -4,000 | $0.00 | $0 | 0 | Nov 7, 2024 |
| Nov 5, 2024 | Raul Parra Jr. CFO AND TREASURER | MOption exercise Non-qualified stock options (right to buy)derivative | -30,000 | $0.00 | $0 | 0 | Nov 7, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Martha Goldberg AronsonPresident and CEO
- Lonny J. Carpenterdirector
- Stephen C. Evansdirector
- David Floyddirector
- Thomas James Gundersondirector
- Laura S. Kaiserdirector
- Fred P. LampropoulosExecutive Chairman
- Sheri LewisEVP of Global Operations
- Michael R. McDonnellcfo, officer, director
- F. Ann Millnerdirector
- Raul Parra Jr.CFO AND TREASURER
- Silvia Perezdirector
- Neil PetersonCHIEF OPERATING OFFICER
- Michel J. VoigtCHIEF HUMAN RESOURCES OFFICER
- Lynne N. Warddirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.